World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
34451
World Ranking
7122
National Ranking
3742

Overview

Jeffrey A. Golden is affiliated with Brigham and Women's Hospital in the United States and has contributed extensively to medical research, particularly in the fields of pulmonary and respiratory medicine and surgery. Their research output includes a significant focus on interstitial lung diseases, transplant-related outcomes, and molecular biology within medicine.

The scientist's work spans various main fields, including medicine, with subfields concentrating on pulmonary and respiratory medicine, surgery, epidemiology, molecular biology, and oncology.

  • Transplantation: Methods and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Polyomavirus and related diseases
  • Mechanical Circulatory Support Devices
  • Renal Transplantation Outcomes and Treatments
  • Tracheal and airway disorders
  • Pneumocystis jirovecii pneumonia detection and treatment

Jeffrey A. Golden has published frequently in notable venues such as:

  • The Journal of Heart and Lung Transplantation
  • American Journal of Transplantation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Nature Communications

Frequent co-authors include Jonathan P. Singer, Steven R. Hays, John R. Greenland, Jasleen Kukreja, and Daniel R. Calabrese, illustrating collaborative work across multiple projects. These collaborations contribute to a substantial body of knowledge in their research areas.

Key recent publications by Jeffrey A. Golden include:

  • "Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease," 2020, Nature Communications
  • "Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial," 2020, The Lancet Respiratory Medicine
  • "A pathology foundation model for cancer diagnosis and prognosis prediction," 2024, Nature
  • "Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study," 2022, The Lancet Respiratory Medicine
  • "Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary Fibrosis," 2020, New England Journal of Medicine

The diversity of their research topics reflects a comprehensive approach toward diseases affecting the lungs and transplant outcomes. The inclusion of studies focused on molecular biology and cancer diagnosis highlights an interdisciplinary perspective within their scientific work.

Best Publications

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

    Tullia Lindsten;Andrea J. Ross;Ayala King;Wei Xing Zong

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease

    Marta Olah;Vilas Menon;Naomi Habib;Naomi Habib;Mariko F. Taga

  • Semaphorin III is needed for normal patterning and growth of nerves, bones and heart

    Oded Behar;Jeffrey A. Golden;Hiroshi Mashimo;Frederick J. Schoen

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Bronchoalveolar Lavage and Transbronchial Biopsy for the Diagnosis of Pulmonary Infections in the Acquired Immunodeficiency Syndrome

    C Broaddus;M D Dake;M S Stulbarg;W Blumenfeld

  • Single cell RNA sequencing of human microglia uncovers a subset that is associated with Alzheimer’s disease: Molecular and cell biology: Inflammatory and microglia‐mediated mechanisms in AD

    Marta Olah;Vilas Menon;Naomi Habib;Mariko Taga

  • Intrapulmonary Pharmacokinetics of Linezolid

    John E. Conte;Jeffrey A. Golden;Juliana Kipps;Elisabeth Zurlinden

  • Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.

    R B Himelman;M Stulbarg;B Kircher;E Lee

  • Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum

    Juliane Najm;Denise Horn;Isabella Wimplinger;Jeffrey A Golden

  • Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial

    Ganesh Raghu;Rachel Million-Rousseau;Adele Morganti;Loïc Perchenet

  • High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity.

    J S Klein;G Gamsu;W R Webb;J A Golden

  • Bronchial hyperirritability in healthy subjects after exposure to ozone.

    J A Golden;J A Nadel;H A Boushey

  • mTOR cascade activation distinguishes tubers from focal cortical dysplasia

    Marianna Baybis;Jia Yu;Allana Lee;Jeff A. Golden

  • Development of the superior temporal neocortex is anomalous in trisomy 21.

    Jeffrey A. Golden;Bradley T. Hyman

  • Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.

    Jeffrey Alan Golden

  • Expression of Normal and Mutant Huntingtin in the Developing Brain

    Pradeep G. Bhide;Michelle Day;Ellen Sapp;Cordula Schwarz

  • Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.

    John E. Conte;Jeffrey A. Golden;Mary Grace Kelly;Elisabeth Zurlinden

  • Does Chronic Microaspiration Cause Idiopathic Pulmonary Fibrosis

    Joyce S. Lee;Harold R. Collard;Ganesh Raghu;Matthew P. Sweet

Frequent Co-Authors

Paul D. Blanc
Paul D. Blanc University of California, San Francisco
Paul J. Wolters
Paul J. Wolters University of California, San Francisco
Harold R. Collard
Harold R. Collard University of California, San Francisco
Eric D. Marsh
Eric D. Marsh Children's Hospital of Philadelphia
William B. Dobyns
William B. Dobyns University of Minnesota
Patricia P. Katz
Patricia P. Katz University of California, San Francisco
Michael A. Matthay
Michael A. Matthay University of California, San Francisco
George H. Caughey
George H. Caughey University of California, San Francisco
Talmadge E. King
Talmadge E. King University of California, San Francisco
Constance L. Cepko
Constance L. Cepko Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring a future in medicine, several related online degrees and career options can expand your opportunities in the healthcare sector. Many learners are looking for ways to enter or advance in healthcare without following the traditional MD pathway.

For those interested in nursing leadership and advanced practice, consider reviewing the cheapest dnp programs to become a Doctor of Nursing Practice with minimal financial burden. If pharmacy is your interest, numerous pharmd online programs offer greater flexibility for working professionals.

Entry-level options like a him associate degree online can lead to vital roles in the management of medical records and health information systems. Alternatively, affordable training is available for those seeking a quick start in administrative roles — look into affordable medical billing and coding programs for a cost-effective pathway into the healthcare industry.

With the rise of online learning, these degree and certificate programs offer diverse routes into healthcare, providing both flexibility and affordability.

Best Scientists Citing Jeffrey A. Golden

Trending Scientists